Beyond Epidiolex, GW also has a late-stage cannabis extract spray – nabiximols – which is in phase 3 testing in the US for spasticity caused by multiple sclerosis. The first data from that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback